MedPath

Evaluation of the preventive effect of bisoprolol fumarate on postoperative hypertension and atrial fibrillation in in eldery patient on acute and chronic phase.

Phase 4
Conditions
Postoperative atrial fibrillation
Registration Number
JPRN-UMIN000004600
Lead Sponsor
Tohoku University Hospital Cardiovascular Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

patients on beta-blocker preoperatively patients with likelihood for ostoperative beta-blocker therapy co-morbid bronchial asthma (FEV1.0 less than 1000ml) co-morbid diabetes mellitus (HbA1c more than 8 percent) persistent atrial fibrillation before entering ICU the case already implanted permanent pacemaker allergic to bisoprolol fumarate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Occurrence of postoperative atrial fibrillation
Secondary Outcome Measures
NameTimeMethod
the activated level of sympathetic nerve(Holter ECG) cardiovascular event level of inflammatory biomarker
© Copyright 2025. All Rights Reserved by MedPath